Skip to the page

Data / Medical devices / Test, Carbohydrate Deficient Transferrin

Test, Carbohydrate Deficient Transferrin (NAO): 3 FDA-registered makers in 3 countries

3 establishments in 3 countries are registered with the FDA to make Test, Carbohydrate Deficient Transferrin (product code NAO, Class 1, 21 CFR 862.1360). 1 of them has a 510(k) clearance or PMA approval on file and 0 have a recall event. The FDA has issued 3 510(k) clearances under this code, the latest on August 25, 2006, and lists 2 recall events (0 Class I). FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

Product code
NAO
Device class
1
Regulation
862.1360
Medical specialty
Clinical Chemistry

Makers by country

CountryMakers
Germany1
China1
France1

Makers of Test, Carbohydrate Deficient Transferrin

Registered establishments that manufacture, contract manufacture, remanufacture, reprocess or own the specification of this device, with the 510(k) clearances, PMA approvals and recalls the FDA files under each. Best documented first.

MakerLocationRole510(k) clearancesLatest clearancePMA approvalsRecall eventsClass ISource
Siemens Healthcare Diagnostics Products GmbHMARBURG Hesse, GermanyManufacturer1August 25, 2006000api.fda.gov
Biobase Biodustry(shandong)co., LtdJinan Shandong, ChinaManufacturer0000api.fda.gov
SebiaEVRY Essonne, FranceManufacturer0000api.fda.gov

Updated August 25, 2006. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.